ArticleRMD open2022

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.

Laura Boekel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.